Loading
A phase 2/3 trial of fOLFOX (5-FU, leucovorin, oxaliplatin), fluorouracil (5-FU), serplulimab and bevacizumab (glioblastoma use) in colorectal cancer, run by Sun Yat-sen University, now recruiting.
Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients is a phase 2/3, randomised interventional study registered as NCT06280495 by Sun Yat-sen University, with a registry enrolment figure of 156 participants, started 2024-02-01 and due to reach its primary completion in 2026-12-31. Interventions recorded: Oxaliplatin; Fluorouracil; Serplulimab; Bevacizumab. Conditions listed: Colorectal Cancer; Liver Metastases. Primary outcome: 3-year Progression-Free Survival Rate. Colorectal eligibility wording from the registry: "* Histologically confirmed colorectal adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.
Shares Bevacizumab (glioblastoma use), FOLFOX (5-FU, leucovorin, oxaliplatin), Fluorouracil (5-FU), Platinum agents and the tag colorectal-deep-dive.
Shares Serplulimab, FOLFOX (5-FU, leucovorin, oxaliplatin), Platinum agents, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Serplulimab, FOLFOX (5-FU, leucovorin, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), FOLFOX (5-FU, leucovorin, oxaliplatin), Fluorouracil (5-FU), Platinum agents and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), FOLFOX (5-FU, leucovorin, oxaliplatin), Fluorouracil (5-FU), Platinum agents and the tag colorectal-deep-dive.
Shares Serplulimab, Bevacizumab (glioblastoma use), Platinum agents, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Serplulimab, FOLFOX (5-FU, leucovorin, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), FOLFOX (5-FU, leucovorin, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.